PRJNA552443
Whole-exome sequencing data from renal cancer patient-derived xenograft tumors treated with vehicle or temsirolimus.
We kept 2 types of primary xenograft models (KURC;Kyoto University Renal Cancer-1,3) derived from human renal cell carcinoma tissues, and 10 mg/kg of temsirolimus or vehicle was intraperitoneally administered.We performed whole-exome sequencing to compare the gene alterations of temsirolimus-treated primary xenograft tumors with that of vehicle-treated.